Purple Biotech Ltd banner

Intrinsic Value

Is PPBT undervalued or overvalued?

See the intrinsic value estimate for Purple Biotech Ltd and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

PPBT Intrinsic Value
LOCKED
Unlock
Today vs. history

PPBT looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with PPBT’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor PPBT
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price ₪1
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to PPBT

Fundamental Analysis

What Purple Biotech Does

Pharmaceuticals Health Care

Purple Biotech Ltd. is a clinical-stage company, which engages in developing first-in-class therapies that seek to overcome tumor immune evasion and drug resistance. The company is headquartered in Rehovot, Central(Hamerkaz) and currently employs 10 full-time employees. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways.

Headquarters
Israel IL
Employees
10
IPO date
Sep 3, 1978
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Purple Biotech Ltd

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

What is the Intrinsic Value of one PPBT stock?

The intrinsic value for Purple Biotech Ltd (PPBT) under the Base Case is hidden ILS.

Is PPBT stock undervalued or overvalued?

Compared with the current market price of 1 ILS, the stock appears hidden.

Back to Top